CSII - Cardiovascular Systems, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2019
30/06/2018
30/06/2017
Total revenue
262,233
248,017
217,043
204,906
Cost of revenue
52,077
47,680
39,484
39,441
Gross profit
210,156
200,337
177,559
165,465
Operating expenses
Research development
41,275
33,462
26,756
22,911
Selling general and administrative
178,998
167,700
148,569
144,096
Total operating expenses
220,946
201,162
175,325
167,007
Operating income or loss
-10,790
-825
2,234
-1,542
Interest expense
1,891
1,684
1,717
500
Total other income/expenses net
-
760
-390
-47
Income before tax
-10,434
-65
1,844
-1,706
Income tax expense
167
190
132
86
Income from continuing operations
-10,601
-255
1,712
-1,792
Net income
-10,601
-255
1,712
-1,792
Net income available to common shareholders
-10,601
-255
1,693
-1,792
Basic EPS
-
-0.01
0.05
-0.06
Diluted EPS
-
-0.01
0.05
-0.06
Basic average shares
-
33,536
33,145
32,374
Diluted average shares
-
33,536
33,614
32,374
EBITDA
-
5,065
7,495
2,929